IMCC

IM Cannabis Corp. Common Shares (IMCC)

Stock · NASDAQ · Health Care

$1.36as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 3, 2026

IM Cannabis Completes Sale of IMC Holdings, Retains Israeli Operations. IM Cannabis has finalized the sale of IMC Holdings and its European-focused operations, a move intended to strengthen its balance sheet. The company will retain its Israeli operations, which are being transferred out of the IMCC entity. This corporate restructuring occurs while a DEA judge pauses a hearing on marijuana rescheduling, citing gaps in federal processes.

Active signals

Support level
$0.129425
Industry
Medicinal Chemicals and Botanical Products

What IMCC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike32-19.4%25%
Bollinger Band Breakdown26-16.4%19%
Bollinger Band Breakout16-19.5%31%
200-Day Moving Average TouchActive now3-17.6%0%
Any 20-session window (baseline)-13.5%28%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About IMCC

IM Cannabis Corp. engages in importation, distribution and sale of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and full-spectrum cannabis extracts under the IMC, BLKMT, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Vancouver, Canada.

Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Employees
44

Fundamentals

1-day range
$1.25$1.38
Market cap
$768.0K
P/E (trailing)
—
P/E (forward)
-1.02
EPS (trailing)
$-2.06
Dividend yield
—
Beta
2.25
Avg. volume
2.80M
Dividend pay date
June 18, 2018
52-week range
$0.475$3.16

IM Cannabis Corp. Common Shares Competitors

Chosen by industry and closest market cap.

  • IMCC
    IM Cannabis Corp. Common Shares
    $1.39
    ▲ 4.51%
    Market cap $768.0KP/E —
    $0.475$3.16
  • XXII
    22nd Century Group Inc. Common Stock
    $0.335
    ▼ 46.57%
    Market cap $2.23MP/E —
    $0.63411$540
  • AKAN
    Akanda Corp. Common Shares
    $1.2
    ▼ 8.40%
    Market cap $2.90MP/E —
    $1.27$78.9
  • BON
    Bon Natural Life Limited Class A Ordinary Shares
    $1.14
    ▲ 0.53%
    Market cap $8.86MP/E —
    $0.95$2.34
  • MTEX
    Mannatech Incorporated Common Stock
    $7.13
    ▲ 0.00%
    Market cap $9.84MP/E —
    $3.8$12.45
  • NAII
    Natural Alternatives International Inc. Common Stock
    $1.15
    ▲ 2.68%
    Market cap $14.94MP/E —
    $1.08$4.96
  • BTMD
    Biote Corp. Class A Common Stock
    $1.09
    ▼ 2.25%
    Market cap $61.26MP/E 6.81
    $1$3.26

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.